1
|
Breen N, Kessler LG and Brown ML: Breast
cancer control among the underserved – an overview. Breast Cancer
Res Treat. 40:105–115. 1996.
|
2
|
Elledge RM, Clark GM, Chamness GC and
Osborne CK: Tumor biologic factors and breast cancer prognosis
among white, Hispanic and black women in the United States. J Natl
Cancer Inst. 86:705–712. 1994. View Article : Google Scholar : PubMed/NCBI
|
3
|
Burns RB, McCarthy EP, Freund KM, Marwill
SL, Shwartz M, Ash A and Moskiwitz MA: Black women receive less
mammography even with similar use of primary care. Ann Intern Med.
125:173–182. 1996. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chang SW, Kerlikowske K, Napoles-Springer
A, Posner SF, Sickles EA and Perez-Stable EJ: Racial differences in
timeliness of follow-up after abnormal screening mammography.
Cancer. 78:1395–1402. 1996. View Article : Google Scholar : PubMed/NCBI
|
5
|
Facione NC: Delay versus help seeking for
breast cancer symptoms: a critical review of the literature on
patient and provider delay. Soc Sci Med. 36:1521–1534. 1993.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Gordon NH, Crowe JP, Brumberg DJ and
Berger NA: Socioeconomic factors and race in breast cancer
recurrence and survival. Am J Epidemiol. 135:609–618.
1992.PubMed/NCBI
|
7
|
Singh GK, Miller BA and Hankey BF:
Changing area socioeconomic patterns in US cancer mortality,
1950–1998: part II – lung and colorectal cancers. J Natl Cancer
Inst. 94:916–925. 2002.
|
8
|
Wells BL and Horm JW: Stage at diagnosis
in breast cancer: race and socioeconomic factors. Am J Public
Health. 82:1383–1385. 1992. View Article : Google Scholar : PubMed/NCBI
|
9
|
Edwards B, Howe HL, Ries L, Thun M,
Rosenberg H, Wingo P, Jemal A and Feigal E: Annual report to the
nation on the status of cancer, 1973–1999, featuring implications
of age and aging on US cancer burden. Cancer. 94:2766–2792.
2000.
|
10
|
Smigal C, Jemal A, Ward E, Cokkinides V,
Smith R, Howe HL and Thun M: Trends in breast cancer by race and
ethnicity: update 2006. CA Cancer J Clin. 56:168–183. 2006.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Benz CC, Campisi J, Cohen HJ, Ershler WB,
Haubein L and Irminger-Finger I: Meeting report: translational
research at the aging and cancer interface. Cancer Res.
67:4560–4563. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Geigl JB, Langer S, Barwisch S, Pfleghaar
K, Lederer G and Speicher MR: Analysis of gene expression patterns
and chromosomal changes associated with aging. Cancer Res.
64:8550–8557. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Issa JP: Aging, DNA methylation and
cancer. Crit Rev Oncol Hematol. 32:31–43. 1999. View Article : Google Scholar : PubMed/NCBI
|
14
|
Richardson B: Impact of aging on DNA
methylation. Ageing Res Rev. 2:245–261. 2003. View Article : Google Scholar
|
15
|
Ershler WB and Longo DL: Aging and cancer:
issues of basic and clinical science. J Natl Cancer Inst.
89:1489–1497. 1997. View Article : Google Scholar : PubMed/NCBI
|
16
|
Balducci L and Ershler WB: Cancer and
ageing: a nexus at several levels. Nat Rev Cancer. 5:655–662. 2005.
View Article : Google Scholar : PubMed/NCBI
|
17
|
DePinho RA: The age of cancer. Nature.
408:248–254. 2000. View
Article : Google Scholar
|
18
|
Eppenberger-Castori S, Moore DH Jr, Thor
AD, Edgerton SM, Kueng W, Eppenberger U and Benz CC: Age-associated
biomarker profiles of human breast cancer. Int J Biochem Cell Biol.
34:1318–1330. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Rudolph P, Olsson H, Bonatz G, Ratjen V,
Bolte H, Baldetorp B, Fernö M, Parwaresch R and Alm P: Correlation
between p53, c-erbB-2, and topoisomerase IIa expression, DNA
ploidy, hormonal receptor status and proliferation in 356
node-negative breast carcinomas: prognostic implications. J Pathol.
187:207–216. 1999. View Article : Google Scholar
|
20
|
Rapiti E, Fioretta G, Verkooijen HM,
Vlastos G, Schafer P, Sappino AP, Kurtz J, Neyroud-Caspar I and
Bouchardy C: Survival of young and older breast cancer patients in
Geneva from 1990 to 2001. Eur J Cancer. 41:1446–1452. 2005.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Harvey JM, Clark GM, Osborne CK and Allred
DC: Estrogen receptor status by immunohistochemistry is superior to
the ligand binding assay for predicting response to adjuvant
endocrine therapy in breast cancer. J Clin Oncol. 17:1474–1481.
1999.
|
22
|
Quong J, Eppenberger-Castori S, Moore D
III, Scott GK, Birrer MJ, Kueng W, Eppenberger U and Benz CC:
Age-dependent changes in breast cancer hormone receptor and oxidant
stress markers. Breast Cancer Res Treat. 76:221–236. 2002.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Shoker BS, Jarvis C, Sibson DR, Walker C
and Sloane JP: Oestrogen receptor expression in the normal and
pre-cancerous breast. J Pathol. 188:237–244. 1999. View Article : Google Scholar : PubMed/NCBI
|
24
|
Creighton C, Cordero K, Larios J, Miller
R, Johnson M, Chinnaiyan A, Lippman M and Rae J: Genes regulated by
estrogen in breast tumor cells in vitro are similarly regulated in
vivo in tumor xenografts and human breast tumors. Genome Biol.
7:R282006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Horwitz KB and McGuire WL: Estrogen
control of progesterone receptor in human breast cancer. J Biol
Chem. 253:2223–2228. 1978.PubMed/NCBI
|
26
|
Arpino G, Weiss H, Lee AV, Schiff R, De
Placido S, Osborne CK and Elledge RM: Estrogen receptor-positive,
progesterone receptor-negative breast cancer: association with
growth factor receptor expression and tamoxifen resistance. J Natl
Cancer Inst. 97:1254–1261. 2005. View Article : Google Scholar
|
27
|
Huang HJ, Neven P, Drijkoningen M, et al:
Association between HER-2/neu and the progesterone receptor in
oestrogen-dependent breast cancer is age-related. Breast Cancer Res
Treat. 91:81–87. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ghafoor A, Jemal A, Ward E, Cokkinides V,
Smith P and Thun M: Trends in breast cancer by race and ethnicity.
CA Cancer J Clin. 53:342–355. 2003. View Article : Google Scholar
|
29
|
Li CI, Malone KE and Daling JR:
Differences in breast cancer hormone receptor status and histology
by race and ethnicity among women 50 years of age and older. Cancer
Epidemiol Biomarkers Prev. 11:301–307. 2002.PubMed/NCBI
|
30
|
Joslyn SA: Hormone receptors in breast
cancer: racial differences in distribution and survival. Breast
Cancer Res Treat. 73:45–59. 2002. View Article : Google Scholar : PubMed/NCBI
|
31
|
Newman LA, Mason J, Cote D, Vin Y, Carolin
K, Bouwman D and Colditz GA: African-American ethnicity,
socioeconomic status and breast cancer survival: a meta-analysis of
14 studies involving over 10,000 African-American and 40,000 white
American patients with carcinoma of the breast. Cancer.
94:2844–2854. 2002. View Article : Google Scholar
|
32
|
Sweeney C, Giuliano AR, Baumgartner KB,
Byers T, Herrick JS, Edwards SL and Slaterry ML: Oral, injected and
implanted contraceptives and breast cancer risk among US Hispanic
and non-Hispanic white women. Int J Cancer. 21:2517–2523. 2007.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Hsu JL, Glaser SL and West DW:
Racial/ethnic differences in breast cancer survival among San
Francisco Bay Area women. J Natl Cancer Inst. 89:1311–1312. 1997.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Chevarley F and White E: Recent trends in
breast cancer mortality among white and black US women. Am J Public
Health. 87:775–781. 1997. View Article : Google Scholar : PubMed/NCBI
|
35
|
Frost F, Tollestrup K, Hunt WC, Gilliland
F, Key CR and Urbina CE: Breast cancer survival among New Mexico
Hispanic, American Indian and non-Hispanic white women (1973–1992).
Cancer Epidemiol Biomarkers Prev. 4:861–866. 1996.PubMed/NCBI
|
36
|
Sugarman JR, Dennis LK and White E: Cancer
survival among American Indians in western Washington state (United
States). Cancer Causes Control. 5:440–448. 1994. View Article : Google Scholar
|
37
|
Meng L, Maskarinec G and Lee J: Ethnicity
and conditional breast cancer survival in Hawaii. J Clin Epidemiol.
50:1289–1296. 1997. View Article : Google Scholar : PubMed/NCBI
|
38
|
Meng L, Maskarinec G and Wilkens L: Ethnic
differences and factors related to breast cancer survival in
Hawaii. Int J Epidemiol. 26:1151–1158. 1997. View Article : Google Scholar : PubMed/NCBI
|
39
|
McGuire WL and Clark GM: Prognostic
factors and treatment decisions in axillary-node-negative breast
cancer. N Engl J Med. 326:1756–1761. 1992. View Article : Google Scholar : PubMed/NCBI
|
40
|
Du Toit RS, Locker AP, Ellis IO, Elston
CW, Nicholson RI, Robertson JFR and Blamey RW: An evaluation of
differences in prognosis, recurrence patterns and receptor status
between invasive lobular and other invasive carcinomas of the
breast. Eur J Surg Oncol. 17:251–257. 1991.PubMed/NCBI
|
41
|
Gapstur SM, Dupuis J, Gann P, Collila S
and Winchester DP: Hormone receptor status of breast tumors in
black. Hispanic and non-Hispanic white women: an analysis of 13,239
cases. Cancer. 77:1465–1471. 1996. View Article : Google Scholar : PubMed/NCBI
|
42
|
Joslyn SA and West MM: Racial differences
in breast carcinoma survival. Cancer. 88:114–123. 2000. View Article : Google Scholar : PubMed/NCBI
|
43
|
Pegoraro RJ, Karnan V, Nirmul D and Joubet
SM: Estrogen and progesterone receptors in breast cancer among
women of different racial groups. Cancer Res. 46:2117–2120.
1986.PubMed/NCBI
|
44
|
Klonoff-Cohen HS, Schaffroth LB, Edelstein
SL, Molgaard C and Saltzstein SL: Breast cancer histology in
whites, African Americans, Hispanics, Asians and Pacific Islanders.
Ethnicity Health. 3:189–198. 1998. View Article : Google Scholar
|
45
|
Li CI, Weiss NS, Stanford JL and Daling
JR: Hormone replacement therapy in relation to risk of lobular and
ductal breast cancer in middle-aged women. Cancer. 88:2570–2577.
2000. View Article : Google Scholar : PubMed/NCBI
|
46
|
Lyons TR, Schedin PJ and Borges VFJ:
Pregnancy and breast cancer: when they collide. Mammary Gland Biol
Neoplasia. 14:87–98. 2009. View Article : Google Scholar : PubMed/NCBI
|
47
|
Li CI and Daling JR: Changes in breast
cancer incidence rates in the United States by histology subtype
and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev.
16:2773–2780. 2007. View Article : Google Scholar : PubMed/NCBI
|
48
|
Sellers TA: Genetic factors in the
pathogenesis of breast cancer: their role and relative importance.
J Nutr. 127:S929–S932. 1997.PubMed/NCBI
|
49
|
Thomas DB and Karagas MR: Migrant studies.
Cancer Epidemiology and Prevention. 2nd edition. Schottenfeld D and
Fraumeni JF Jr: Oxford University Press; New York: pp. 236–254.
1996
|
50
|
Robbins AS, Brescianini S and Kelsey JL:
Regional differences in known risk factors and the higher incidence
of breast cancer in San Francisco. J Natl Cancer Inst. 89:960–965.
1997. View Article : Google Scholar : PubMed/NCBI
|
51
|
Cornelisse CJ, Cornelis RS and Devilee P:
Genes responsible for familiar breast cancer. Path Res Pract.
192:684–693. 1996. View Article : Google Scholar : PubMed/NCBI
|
52
|
Szabo CI and King MC: Population genetics
of BRCA1 and BRCA2. Am J Hum Genet. 60:1013–1020. 1997.PubMed/NCBI
|
53
|
Levy-Lahad E, Lahad A, Eisenberg S, et al:
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel:
frequency and differential penetrance in ovarian cancer and in
breast-ovarian cancer families. Am J Hum Genet. 60:1059–1067.
1997.PubMed/NCBI
|
54
|
Berman DB, Wagner-Costalas J, Schultz DC,
Lynch HT, Daly M and Godwin AK: Two distinct origins of a common
BRCA1 mutation in breast-ovarian cancer families: a genetic study
of 15 185delAG mutation kindreds. Am J Hum Genet. 58:1166–1176.
1996.PubMed/NCBI
|
55
|
Struewing JP, Abeliovich D, Peretz T,
Avishai N, Kaback MM, Collins FS and Brody LC: The carrier
frequency of the BRCA1 185delAG mutation is approximately 1 percent
in Ashkenazi Jewish individuals. Nat Genet. 11:198–200. 1995.
View Article : Google Scholar : PubMed/NCBI
|
56
|
Gayther SA, Mazoyer WW, Russell PA,
Harrington PA, Mathias Chiano M and Seal S: Germline mutations of
the BRCA1 gene in breast/ovarian cancer families provide evidence
for a phenotype/genotype correlation. Nat Genet. 11:428–433. 1995.
View Article : Google Scholar : PubMed/NCBI
|
57
|
Carrozza SE and Lowe HL: Patterns of
cancer incidence among US Hispanics/Latinos, 1995–2000. Cancer
Causes Control. 17:1067–1075. 2006.PubMed/NCBI
|
58
|
Ogden CL, Carroll MD, Curtin LR, McDowell
MA, Tabak CJ and Flegal KM: Prevalence of overweight and obesity in
the United States, 1999–2004. JAMA. 295:1549–1555. 2006.
|
59
|
Murtaugh MA, Herrick JS, Sweeney C, et al:
Diet composition and risk of overweight and obesity in women living
in the south western United States. J Am Diet Assoc. 107:1311–1321.
2007. View Article : Google Scholar : PubMed/NCBI
|
60
|
Slattery ML, Sweeney C, Edwards S, et al:
Body size, weight change, fat distribution and breast cancer risk
in Hispanic and non-Hispanic white women. Breast Cancer Res Treat.
38:33–41. 2006.PubMed/NCBI
|